Illumina, Inc. (ILMN) stock

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3

Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3023% above fair value

$235.99−54.07 (-18.64%)

Close on Oct 30, 2026Market cap $35.63BP/E 40.5Yield –

Earnings

Illumina's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 4, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

$1.13B

+4.6% on a year earlier

non ‑ GAAP diluted EPS, excluding tariff refunds, Q3 FY2026

$1.44

$1.34 a year earlier

Latest guidance

Raised

Oct 29, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Illumina's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 28, 2026	Feb 4, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 28, 2026	Oct 29, 2026after the close	$1.13B	+4.6%	$1.43	$1.44	Release
Q2 FY2026ended Jun 28, 2026	Jul 30, 2026after the close	$1.16B	+9.4%	$1.35	$1.31	Release
Q1 FY2026ended Mar 29, 2026	Apr 30, 2026after the close	$1.09B	+4.7%	$0.87	$1.15	Release
Q4 FY2025ended Dec 28, 2025	Feb 5, 2026after the close	$1.16B	+5.5%	$2.16	$1.35	Release
Q3 FY2025ended Sep 28, 2025	Oct 30, 2025after the close	$1.08B	0.0%	$0.98	$1.34	Release
Q2 FY2025ended Jun 29, 2025	Jul 31, 2025after the close	$1.06B	-4.7%	$1.49	$1.19	Release
Q1 FY2025ended Mar 30, 2025	May 8, 2025after the close	$1.04B	-3.6%	$0.82	–	Release
Q4 FY2024ended Dec 29, 2024	Feb 6, 2025after the close	$1.10B	-1.8%	$0.73	$0.95	Release
Q3 FY2024ended Sep 29, 2024	Nov 4, 2024after the close	$1.08B	-3.6%	$4.42	$1.14	Release
Q2 FY2024ended Jun 30, 2024	Aug 6, 2024after the close	$1.11B	-5.8%	-$12.48	$0.36	Release
Q1 FY2024ended Mar 31, 2024	May 2, 2024after the close	$1.08B	-0.9%	-$0.79	$0.09	Release
Q4 FY2023ended Dec 31, 2023	Feb 8, 2024after the close	$1.12B	+3.7%	-$1.11	$0.14	Release
Q3 FY2023ended Oct 1, 2023	Nov 9, 2023after the close	$1.12B	0.0%	-$4.77	$0.33	Release
Q2 FY2023ended Jul 2, 2023	Aug 9, 2023after the close	$1.18B	+1.7%	-$1.48	$0.32	Release
Q1 FY2023ended Apr 2, 2023	Apr 25, 2023after the close	$1.09B	-10.7%	$0.02	$0.08	Release
Q4 FY2022ended Jan 1, 2023	Feb 7, 2023after the close	$1.08B	-9.8%	-$0.89	$0.14	Release
Q3 FY2022ended Oct 2, 2022	Nov 3, 2022after the close	$1.12B	+1.1%	-$24.26	$0.34	Release
Q2 FY2022ended Jul 3, 2022	Aug 11, 2022after the close	$1.16B	–	-$3.40	$0.57	Release
Q1 FY2022ended Apr 3, 2022	May 5, 2022after the close	$1.22B	–	$0.55	$1.07	Release
Q4 FY2021ended Jan 2, 2022	Feb 10, 2022after the close	$1.20B	–	$0.71	$0.75	Release
Q3 FY2021ended Oct 3, 2021	Nov 4, 2021after the close	$1.11B	–	$2.08	$1.45	Release
Q2 FY2021ended Jul 4, 2021	Aug 5, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Apr 4, 2021	Apr 5, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Jan 3, 2021	Jan 12, 2021after the close	–	–	–	–	Filing
Q3 FY2020ended Sep 27, 2020	Oct 29, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Illumina's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Reported revenue growth	FY2026	+4% – +6%	–	New	Apr 30, 2026
ROW organic revenue growthnon-GAAP	FY2026	+5%	–	New	Jul 30, 2026
Total company revenueGAAP	FY2026	$4.50B – $4.60B	–	New	Feb 5, 2026
Total revenuenon-GAAP	FY2026	$4.64B – $4.66B	–	New	Oct 29, 2026
Total revenue	FY2026	$4.60B – $4.64B	$4.52B – $4.62B	Raised	Jul 30, 2026
Non-GAAP operating marginnon-GAAP	FY2026	23.6%	23.3% – 23.5%	Raised	Oct 29, 2026
Non-GAAP operating marginnon-GAAP	FY2026	23.4% – 23.6%	23.4% – 23.6%	Reaffirmed	Jul 30, 2026
Non-GAAP diluted EPSnon-GAAP	FY2026	$5.40 – $5.45	$5.05 – $5.20	Raised	Oct 29, 2026
Non-GAAP diluted EPSnon-GAAP	FY2026	$5.30 – $5.40	$5.15 – $5.30	Raised	Jul 30, 2026
Ex-China Organic revenue growthnon-GAAP	FY2026	+2% – +4%	–	New	Feb 5, 2026
ROW organic revenue growthnon-GAAP	FY2026	+2% – +4%	–	New	Apr 30, 2026

Guidance vs results

The last range Illumina gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2025	Revenue growth	+0.5% – +1.5%	-0.71%Σ4Q	Below range
Q4 FY2024	Revenue	$1.07B	$1.10B	Above range

Guidance history

Every forecast Illumina put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Oct 29, 2026	Non-GAAP diluted EPS	FY2026	$5.40 – $5.45	Raised
Oct 29, 2026	Non-GAAP operating margin	FY2026	23.6%	Raised
Oct 29, 2026	Total revenue	FY2026	$4.64B – $4.66B	New
Jul 30, 2026	Non-GAAP diluted EPS	FY2026	$5.30 – $5.40	Raised
Jul 30, 2026	Non-GAAP operating margin	FY2026	23.4% – 23.6%	Reaffirmed
Jul 30, 2026	Total revenue	FY2026	$4.60B – $4.64B	Raised
Jul 30, 2026	ROW organic revenue growth	FY2026	+5%	New
Apr 30, 2026	Non-GAAP diluted EPS	FY2026	$5.15 – $5.30	New
Apr 30, 2026	Non-GAAP operating margin	FY2026	23.4% – 23.6%	New
Apr 30, 2026	ROW organic revenue growth	FY2026	+2% – +4%	New
Apr 30, 2026	Total revenue	FY2026	$4.52B – $4.62B	New
Apr 30, 2026	Reported revenue growth	FY2026	+4% – +6%	New
Feb 5, 2026	Non-GAAP diluted EPS	FY2026	$5.05 – $5.20	New
Feb 5, 2026	Non-GAAP operating margin	FY2026	23.3% – 23.5%	New
Feb 5, 2026	Ex-China Organic revenue growth	FY2026	+2% – +4%	New
Feb 5, 2026	Total company revenue	FY2026	$4.50B – $4.60B	New
Oct 30, 2025	Non-GAAP diluted EPS	FY2025	$4.65 – $4.75	Raised
Oct 30, 2025	Non-GAAP operating margin	FY2025	22.75% – 23%	Raised
Oct 30, 2025	Total company constant currency revenue decline	FY2025	-1.5% – -0.5%	Raised
Oct 30, 2025	Revenue growth outside of China	FY2025	+0.5% – +1.5%	Raised
Jul 31, 2025	Non-GAAP diluted EPS	FY2025	$4.45 – $4.55	New
Jul 31, 2025	Non-GAAP operating margin	FY2025	22% – 22.5%	New
Jul 31, 2025	constant currency revenue decline	FY2025	-2.5% – -0.5%	New
May 8, 2025	non-GAAP diluted EPS	FY2025	$4.20 – $4.30	Lowered
May 8, 2025	Non-GAAP operating margin	FY2025	21.5% – 22%	Lowered
May 8, 2025	Revenue outside of the Greater China region	FY2025	0% – +2%	Raised
May 8, 2025	Core Illumina revenue	FY2025	-3% – -1%	New
May 8, 2025	Reported revenue from the Greater China region	FY2025	$165.00M – $185.00M	Lowered
Feb 6, 2025	non-GAAP diluted EPS	FY2025	$4.50 – $4.65	New
Feb 6, 2025	non-GAAP operating margin	FY2025	23%	Reaffirmed
Feb 6, 2025	reported revenue	FY2025	$4.28B – $4.40B	New
Jan 14, 2025	non-GAAP diluted EPS growth	FY2025	+10%	New
Jan 14, 2025	non-GAAP operating margin	FY2025	23%	Lowered
Jan 14, 2025	reported revenue	FY2025	$4.28B – $4.40B	New
Nov 4, 2024	Core Illumina non-GAAP diluted EPS	FY2024	$4.05 – $4.15	Raised
Nov 4, 2024	Core Illumina non-GAAP operating margin	FY2024	21% – 21.5%	Raised
Nov 4, 2024	Core Illumina revenue	Q4 FY2024	$1.07B	New
Nov 4, 2024	Core Illumina revenue	FY2024	-3%	New
Aug 6, 2024	Core Illumina non-GAAP diluted EPS	FY2024	$3.80 – $3.95	New
Aug 6, 2024	Core Illumina non-GAAP operating margin guidance	FY2024	20.5% – 21%	Raised
Aug 6, 2024	Core Illumina revenue guidance	FY2024	-3% – -2%	New
May 2, 2024	Core Illumina non-GAAP operating margin	FY2024	20%	Reaffirmed
Feb 8, 2024	Core Illumina non-GAAP operating margin	FY2024	20%	Lowered
Nov 9, 2023	non-GAAP diluted earnings per share	FY2023	$0.60 – $0.70	Lowered
Nov 9, 2023	GAAP diluted loss per share	FY2023	-$6.67 – -$6.57	Lowered
Nov 9, 2023	NovaSeq X instruments	FY2023	330 – 340	New
Nov 9, 2023	consolidated revenue	FY2023	-3% – -2%	Lowered
Aug 9, 2023	non-GAAP diluted earnings per share	FY2023	$0.75 – $0.90	Lowered
Aug 9, 2023	GAAP diluted loss per share	FY2023	-$2.08 – -$1.93	Lowered
Aug 9, 2023	consolidated revenue growth	FY2023	+1%	Lowered
Apr 25, 2023	non-GAAP diluted earnings per share	FY2023	$1.25 – $1.50	Reaffirmed
Apr 25, 2023	GAAP diluted loss per share	FY2023	-$0.28 – -$0.03	Lowered
Apr 25, 2023	Core Illumina non-GAAP operating margins	FY2025	27%	New
Apr 25, 2023	Core Illumina non-GAAP operating margins	FY2024	25%	New
Apr 25, 2023	GRAIL revenue	FY2023	$90.00M – $110.00M	New
Apr 25, 2023	Core Illumina revenue growth	FY2023	+6% – +9%	Lowered
Apr 25, 2023	consolidated revenue growth	FY2023	+7% – +10%	Reaffirmed
Feb 7, 2023	non-GAAP diluted earnings per share	FY2023	$1.25 – $1.50	New
Feb 7, 2023	GAAP diluted earnings per share	FY2023	$0.03 – $0.28	New
Feb 7, 2023	consolidated revenue growth	FY2023	+7% – +10%	Reaffirmed
Jan 11, 2023	Non-GAAP operating margin for Core Illumina	FY2023	22%	New
Jan 11, 2023	revenue growth	FY2023	+7% – +10%	New
Nov 3, 2022	non-GAAP diluted earnings per share	FY2022	$2.35 – $2.50	Lowered
Nov 3, 2022	GAAP diluted loss per share	FY2022	-$26.56 – -$26.41	Lowered
Aug 11, 2022	non-GAAP diluted earnings per share	FY2022	$2.75 – $2.90	Lowered
Aug 11, 2022	GAAP diluted loss per share	FY2022	-$2.93 – -$2.78	Lowered
Aug 11, 2022	full year revenue	FY2022	+4% – +5%	Lowered
May 5, 2022	non-GAAP earnings per diluted share	FY2022	$4.00 – $4.20	Reaffirmed
May 5, 2022	GAAP earnings per diluted share	FY2022	$2.33 – $2.53	Lowered
May 5, 2022	consolidated revenue growth	FY2022	+14% – +16%	Reaffirmed
Feb 10, 2022	non-GAAP earnings per diluted share	FY2022	$4.00 – $4.20	Reaffirmed
Feb 10, 2022	GAAP earnings per diluted share	FY2022	$3.04 – $3.24	New
Feb 10, 2022	consolidated revenue growth	FY2022	+14% – +16%	New
Jan 11, 2022	consolidated non-GAAP EPS	FY2022	$4.00 – $4.20	New
Jan 11, 2022	non-GAAP operating margin	FY2022	15.5% – 16%	New
Jan 11, 2022	consolidated revenue	FY2022	$5.15B – $5.24B	New
Nov 4, 2021	non-GAAP earnings per diluted share	FY2021	$5.50 – $5.60	New
Nov 4, 2021	GAAP earnings per diluted share	FY2021	$4.41 – $4.51	New
Nov 4, 2021	revenue growth	FY2021	+36%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.